Business Description
Doseology Sciences Inc
NAICS : 541720
SIC : 3741
ISIN : CA2584841043
Total Employee Number:
1Compare
Compare
Traded in other countries / regions
MOOD.CanadaDOSEF.USAVU70.Germany IPO Date
2022-03-17Description
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. It offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.93 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -2.42 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 31 | |||||
3-Year EBITDA Growth Rate | 38.6 | |||||
3-Year EPS without NRI Growth Rate | 41 | |||||
3-Year FCF Growth Rate | 44.8 | |||||
3-Year Book Growth Rate | -37.5 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 30.98 | |||||
9-Day RSI | 37.56 | |||||
14-Day RSI | 38.92 | |||||
3-1 Month Momentum % | -60.26 | |||||
6-1 Month Momentum % | -71.56 | |||||
12-1 Month Momentum % | -87.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.3 | |||||
Quick Ratio | 8.46 | |||||
Cash Ratio | 4.53 | |||||
Days Inventory | 400.9 | |||||
Days Sales Outstanding | 89.22 | |||||
Days Payable | 149.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 24.69 | |||||
Operating Margin % | -1467.9 | |||||
Net Margin % | -1443.21 | |||||
EBITDA Margin % | -1467.9 | |||||
FCF Margin % | -1452 | |||||
OCF Margin % | -1452 | |||||
ROE % | -92.15 | |||||
ROA % | -86.77 | |||||
ROIC % | -266.74 | |||||
ROC (Joel Greenblatt) % | -593.51 | |||||
ROCE % | -93.56 | |||||
Moat Score | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 16.67 | |||||
PB Ratio | 1.09 | |||||
Price-to-Tangible-Book | 1.59 | |||||
EV-to-EBIT | -0.32 | |||||
EV-to-EBITDA | -0.32 | |||||
EV-to-Revenue | 4.72 | |||||
EV-to-FCF | -0.33 | |||||
Price-to-GF-Value | 0.64 | |||||
| Price-to-Net-Current-Asset-Value | 1.59 | |||||
| Price-to-Net-Cash | 3.18 | |||||
Earnings Yield (Greenblatt) % | -312.5 | |||||
FCF Yield % | -96.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Doseology Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.05 | ||
| EPS (TTM) (€) | -0.107 | ||
| Beta | -7.6704 | ||
| 3-Year Sharpe Ratio | 0.8 | ||
| 3-Year Sortino Ratio | 2.53 | ||
| Volatility % | 229.33 | ||
| 14-Day RSI | 38.92 | ||
| 14-Day ATR (€) | 0.01323 | ||
| 20-Day SMA (€) | 0.084325 | ||
| 12-1 Month Momentum % | -87.02 | ||
| 52-Week Range (€) | 0.0475 - 0.935 | ||
| Shares Outstanding (Mil) | 8.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Doseology Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Doseology Sciences Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2024-02-16 | 0.09 (+0.00%) |
Show
Entries
Doseology Sciences Inc Frequently Asked Questions
What is Doseology Sciences Inc(FRA:VU70)'s stock price today?
The current price of FRA:VU70 is €0.06. The 52 week high of FRA:VU70 is €0.94 and 52 week low is €0.05.
When is next earnings date of Doseology Sciences Inc(FRA:VU70)?
The next earnings date of Doseology Sciences Inc(FRA:VU70) is .
Does Doseology Sciences Inc(FRA:VU70) pay dividends? If so, how much?
Doseology Sciences Inc(FRA:VU70) does not pay dividend.
Press Release
Articles on Doseology Sciences Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers